Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BBH vs FBTAX overlap: 35% of top holdings shared

Bottom line

How much do BBH and FBTAX overlap?

35% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 65.8% of BBH's assets and 27.9% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.

FBTAX holds far more positions (129 vs 25), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

BBHFBTAX
Weight overlap (top 25)35%
Shared holdings10
Weight in shared holdings65.8%27.9%
Total positions25129
Expense ratio0.35%0.94%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings BBH and FBTAX have in common

Holding% of BBH% of FBTAXOverlap
Amgen Inc15.25%2.37%2.37%
Gilead Sciences Inc12.79%5.70%5.70%
Vertex Pharmaceuticals Inc9.10%1.39%1.39%
Revolution Medicines Inc5.27%3.00%3.00%
Argenx SE4.97%3.00%3.00%
Natera Inc4.92%1.43%1.43%
Alnylam Pharmaceuticals Inc3.83%3.62%3.62%
Biogen Inc3.63%2.71%2.71%
Moderna Inc3.36%1.60%1.60%
Insmed Inc2.67%3.05%2.67%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BBH

  1. Regeneron Pharmaceuticals Inc — 6.21%
  2. IQVIA Holdings Inc — 4.31%
  3. Illumina Inc — 3.17%
  4. United Therapeutics Corp — 2.83%
  5. BeOne Medicines Ltd — 2.81%
  6. Incyte Corp — 2.49%
  7. Neurocrine Biosciences Inc — 2.08%
  8. BioNTech SE — 1.94%
  9. Icon Plc — 1.90%
  10. Bio-Techne Corp — 1.54%
  11. Charles River Laboratories International Inc — 1.50%
  12. BioMarin Pharmaceutical Inc — 1.34%
  13. Qiagen Nv — 1.06%
  14. Tempus AI Inc — 0.98%
  15. State Street Global Advisors — 0.06%

Only in FBTAX

  1. Abbvie Inc — 14.71%
  2. Spyre Therapeutics Inc — 3.83%
  3. Dianthus Therapeutics Inc — 3.55%
  4. Cogent Biosciences Inc — 3.25%
  5. Oruka Therapeutics Inc — 3.24%
  6. Ascendis Pharma A/s — 2.99%
  7. Mbx Biosciences Inc — 2.45%
  8. Amylyx Pharmaceuticals Inc — 2.25%
  9. Vaxcyte Inc — 1.97%
  10. Fidelity Revere Street Trust — 1.96%
  11. Relay Therapeutics Inc — 1.58%
  12. Viridian Therapeutics Inc — 1.53%
  13. Kiniksa Pharmaceuticals International Plc — 1.41%
  14. Enliven Therapeutics Inc — 1.25%
  15. Alumis Inc — 1.22%

Asset mix

Asset typeBBHFBTAX
Stocks100.0%98.2%
Cash & short-term funds0.1%2.4%
Preferred stock—1.5%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryBBHFBTAX
US87.3%87.8%
NL6.0%4.3%
DK—3.0%
CH2.8%—
DE1.9%0.1%
IE1.9%—
KY—1.8%
GB—1.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do BBH and FBTAX overlap?
About 35% by weight. 10 securities appear in both funds' top 25 holdings; they make up 65.8% of BBH's assets and 27.9% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do BBH and FBTAX have in common?
The largest shared holdings are Gilead Sciences Inc, Alnylam Pharmaceuticals Inc, Revolution Medicines Inc, Argenx SE, Biogen Inc.
Should I own both BBH and FBTAX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, BBH or FBTAX?
FBTAX is broader, with 129 positions versus 25 for BBH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.